BRCAHRwild:

Ayesha B Alvero1, Sharon Wu2, Alex Farrell2

  • 1C.S. Mott Center for Human Growth and Development, Department of Obstetrics and Gynecology, Wayne State University, Detroit, MI, United States of America; Karmanos Cancer Institute/ Wayne State University, Detroit, MI, United States of America.

Gynecologic oncology
|February 19, 2025
PubMed
概括

这项研究比较了BRCA1/BRCA2突变和野生类型高度血清性卵巢癌 (HGSOC) 的转录组资料. BRCA1突变与不同的免疫特征有关,这表明有针对性的免疫治疗策略.